In order to evaluate perspective appropriateness of MKK3 targeting in CRC patients, we performed IHC analysis on a tissue micro-array (TMA) retrospective cohort of n.178 CRC patients (Supplementary Fig. 1). The gene discussed is MAP2K3; the disease is colorectal carcinoma.